4Marcocci C, Marino M. Treatment of mild, moderate-to-severe and very severe Graves' orbitopathy[J]. Best Practice Res Clin Endoerinol Metab, 2012, 26(3): 325-337.
5Gao Guohong, Mai Jinhui, Qian Yifeng. Meta-analysis of methylprednisolone pulse therapy for Graves' ophthalmopathy[J]. Clinical and Experimental Ophthalmology, 2014, 42: 769-777.
6Zang S, Ponto KA, Kahaly GJ. Intravenous glucocorticoids for Graves' orbitopathy: efficacy and morbidity[J]. J Clin Endocrinol Metab, 2011, 96: 320-332.
7Wei Zhu, Lei Ye, Liyun Shen. A prospective, randomized trial of intravenous glucoeorticoids therapy with different protocols for patients with Graves' ophthalmopathy[J]. J Clin Endoerinol Metab, 2014, 99(6): 1999-2007.
9Lan C, Li C, Yang M. Pretibial myxoedema with autoimmunity and hyperplasia treated with glucocorticoids and surgery[J]. Br J Dermatol, 2012, 166(2): 457-459.
10Deng A, Song D. Multipoint subcutaneous injection of long-acting glucocorticid as a cure for pretibial myxedema thyroid[J]. 2011, 21(1): 83-85.
3Iitaka M, Momotani N, Ishii J, et al. Incidence of subacute thyroiditis recurrences after a prolonged latency: 24-year survey. J Clin Endocrinol Metab, 1996,81:466-469.
4Davies TF,Larsen PR. Thyrotixicosis//Larsen PR, Kronenberg HM, Melmed S. Wlilliams textbook of endocrinology. 10th ed. Philadelphia : Saunders, 2002 : 423-456.
5Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med, 2003,349:2646-2655.
6Fatourechi V, Aniszewski JP, Fatourechi GZ, et al. Clinical features and outcome of subacute thyroiditis in an incidence cohort : Olmsted County, Minnesota, study. J Clin Endocrinol Metab, 2003, 88:2100-2105.
7Ross DS. Syndromes of thyrotoxicosis with low radioactive iodine uptake. Endocrinol Metab Clin North Am, 1998,27 : 169-185.
